Tuesday, November 3, 2009

Kanzius machine to treat cancer


This was by Maryann Yochim revelation of John Kanzius on CBS 60 Minutes "Sunday that he's cancer-killing machine, I tried to explain himself.

"They are willing and praying and hoping for a miracle. It is a life and death goes," said Yochim, President of the John Kanzius Cancer Research Foundation.

"I've been there, and it is a place that has the experience please no one," said Yochim, whose husband died of pancreatic cancer. "That is why we are so stubborn in the research, because many of us have experienced similar difficulties."

Parts of "60 Minutes" segment was filmed over several months in 2008 after the death Kanzius in February with pneumonia, a side effect of chemotherapy for a rare leukemia.

In an interview in August 2008, Leslie Stahl Kanzius said he used the device nine times, and that her blood had been working all summer to improve.

"I decided it was time to try the switch on the turn," said Kanzius.

"Make the switch and try it?" Stahl asked.

"Try to treat you, me," he said. "I have to be adjusted in the machine, and turned for a minute for the first time and did not feel a bit strange."

Stahl then asked if he ever worried that his feelings of good health was "too good to be true."

"Of course, one, if the bubble bursts miracle," he said. "The disease is inexorable. He just keeps pushing and pressing and pushing."

Kanzius device, "works by sending radio waves into the body, heat nanoparticles - small pieces of gold or carbon - hot enough to kill in order to find cancer cells in which they, too, but it has no effect on healthy cells. Specific Antibody nanoparticles provides for certain cancer cells.

Kanzius does not use nanoparticles or if antibodies have to do.

Steel said he has not said lead investigator Steven Curley, MD, of MD Anderson Cancer Center in Houston, about her personal experience, because he thought Curley do not agree and tried to discourage too.

Curley could not be reached for comment Monday. But in the "60 Minutes" segment, "said Stahl, that he was worried about herself treatment could harm the project. He said he did not believe that experience helped Kanzius or contributed to his death.

"I do not believe he was killed. I do not think that it may shorten life in any way. What is killed was John, but unfortunately his leukemia, and toxic effects of treatment," said Curley, referring to the chemotherapy.

Kanzius Marianne Kanzius, shares the conviction of Curley. She said she feared that people think that self-experiment caused the death of her husband.

She said she did not know at first that her late husband was the treatment itself, but when she said, fully supports it.

"I was worried, but I also knew that he was on the radio knew better than anyone else, and I trusted his decision to trust in what he" said Marianne Kanzius.

When asked why he would take the risk, she said, "She had been with him. You had to know how he endured chemotherapy and how his health. There was a constant optimist."

Mark Neidig, manager of the John Kanzius Cancer Research Foundation, said Kanzius discovered that he had tried, which called his camera during a producer of the show before it aired.

"I did what everyone did - go" Wow, "Neidig said." And then you take a step back and say: "I would do the same." We all want to accomplish the same thing and find the cure, the treatment that works. The last thing we want is to pass a trial. "

Neidig said he did not think even Kanzius' experiment goes wrong project work or research in any way. Laboratory tests have shown that the device when used with the nanoparticles and antibodies, is effective to 100 percent "to kill cancer of the pancreas and liver, "he said.

Hold the camera to the national honor can only help the cause, "he said.

"It is only our efforts moving forward," he said. "We're pumped, our passion, and we will see them to bear. We share the dream of John."

Clinical trials are two to four years away, but the research and efforts to a device the size of human progress.

No comments:

Post a Comment